Showing results (2391-2400 of 2,573) with videos related to

Sort By:
Pageof 258
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain MetastasisKimberly L Johung, Norman Yeh, Neil B Desai, et al.
JTO Clinical and Research Reports|January 10, 2022
A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLCD Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2018
Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung CancerCaroline E McCoach, Anh T Le, Katherine Gowan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2005
Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomasGuoan Chen, Mahaveer S Bhojani, Andrew C Heaford, et al.
Plos One|April 11, 2015
Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancerJean-Christophe Brisset, Benjamin A Hoff, Thomas L Chenevert, et al.
Journal of Sport and Health Science|August 16, 2025
Factors associated with concussion during combatives activities in a military training environmentMichael J Aderman, Megan H Roach, Katelyn Ward, et al.
The Journal of Biological Chemistry|May 31, 2025
Paracrine regulation of pancreatic cancer cell response to chemotherapy by GLI2-collagen I signalingRenzo E Vera, Maite G Fernandez-Barrena, Jose M Falero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid TumorsFlorence Atrafi, Harry J M Groen, Lauren A Byers, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 5, 2023
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1-Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical TrialEdward B Garon, Alexander I Spira, Sarah B Goldberg, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2020
Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancerSolange Peters, Alice T Shaw, Benjamin Besse, et al.
Pageof 258